Siltuximab (Sylvant) for treatment of multicentric castleman's disease

Med Lett Drugs Ther. 2015 Jan 5;57(1459):e8.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Antibodies, Monoclonal / therapeutic use*
  • Antineoplastic Agents / therapeutic use*
  • Castleman Disease / diagnosis
  • Castleman Disease / drug therapy*
  • Clinical Trials as Topic / methods
  • Humans

Substances

  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • siltuximab

Supplementary concepts

  • Multi-centric Castleman's Disease